Suchergebnisse - "Kopczynski, Casey C"

PubPharm (39)

1

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension : Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

enthalten in: Advances in therapy | 2023

von Araie, M. | Sugiyama, K. | Aso, K. | +5

2

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

enthalten in: Advances in therapy | 2023

von Araie, M. | Sugiyama, K. | Aso, K. | +5

3

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

enthalten in: Advances in therapy | 2023

von Araie, M. | Sugiyama, K. | Aso, K. | +5

4

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

enthalten in: Advances in therapy | 2023

von Araie, M. | Sugiyama, K. | Aso, K. | +5

5

Eyes on Topical Ocular Disposition : The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility

enthalten in: Journal of medicinal chemistry | 2023

von Gordhan, H. | Miller, S. | Clancy, D. | +12

6

PHASE 2 RANDOMIZED STUDY (ORION-1) OF A NOVEL, BIODEGRADABLE DEXAMETHASONE IMPLANT (AR-1105) FOR THE TREATMENT OF MACULAR EDEMA DUE TO CENTRAL OR BRANCH RETINAL VEIN OCCLUSION

enthalten in: Retina (Philadelphia, Pa.) | 2023

von Singer, M. | Boyer, D. | Williams, S. | +6

7

Effects of netarsudil-family Rho kinase inhibitors on human trabecular meshwork cell contractility and actin remodeling using a bioengineered ECM hydrogel

enthalten in: bioRxiv.org | 2022

von Bagué, T. | Singh, A. | Ghosh, R. | +5

8

Antifibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis

enthalten in: bioRxiv.org | 2021

von Li, G. | Lee, C. | Read, A. | +12

9

A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma

enthalten in: Ophthalmology and therapy | 2021

von Peace, J. | McKee, H. | Kopczynski, C.

10

A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma

enthalten in: Ophthalmology and therapy | 2020

von Peace, J. | McKee, H. | Kopczynski, C.